Selective elimination of amplified CDK4 sequences correlates with spontaneous adipocytic differentiation in liposarcoma

Genes Chromosomes and Cancer

Volumn 48, Issue 11, 2009, Pages 943-952

  Hélias Rodzewicz, Zofia ^a,b   Pédeutour, Florence ^c   Coindre, Jean Michel ^d   Terrier, Philippe ^e   Aurias, Alain ^a,b  

^a INSTITUT CURIE   (France)

^b INSERMU830   (France)

^c UNIVERSITY HOSPITAL OF NICE   (France)

^d INSTITUT BERGONIÉ   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4;

ADIPOCYTE; ANAPHASE; ARTICLE; CELL DIFFERENTIATION; CENTROSOME; CHROMOSOME 12; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; LIPOSARCOMA; MICRONUCLEUS; PRIORITY JOURNAL; X CHROMOSOME;

ADIPOCYTES; ANAPHASE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CENTROMERE; CENTROSOME; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE 4; DNA METHYLATION; GENE AMPLIFICATION; GENE DELETION; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MICRONUCLEI, CHROMOSOME-DEFECTIVE; PROTO-ONCOGENE PROTEINS C-MDM2;

EID: 70349315224     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20696     Document Type: Article

References (45)

1. Abruzzo MA, Mayer M, Jacobs PA. 1985. Aging and aneuploidy: Evidence for the preferential involvement of the inactive X chromosome. Cytogenet Cell Genet 39:275-278. (Pubitemid 16208786)
2. Ambros IM, Rumpler S, Luegmayr A, Hattinger CM, Strehl S, Kovar H, Gadner H, Ambros PF. 1997. Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation-Sign of tumour cell revertance? Eur J Cancer 33:2043-2049.
3. Bassett MD, Schuetze SM, Disteche C, Norwood TH, Swisshelm K, Chen X, Bruckner J, Conrad EU, III, Rubin BP. 2005. Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities: The role of cytogenetics in classification and prognostication. Cancer 103:409-416. (Pubitemid 40129302)
4. Benchetritt M, Hofman V, Venissac N, Brennetot C, Italiano A, Aurias A, Padovani B, Pedeutour F, Hofman P. 2007. Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: Usefulness of cytogenetic and molecular genetic analyses. Cancer Genet Cytogenet 179:150-155. (Pubitemid 350123638)
5. Boise LH, Grant S, Westin EH. 1992. Altered expression of cell cycle related genes including c-myb in a subclone of HL-60 that exhibits reversible differentiation. Cell Growth Differ 3:53-61.
6. Bregman DB, Du L, van der Zee S, Warren SL. 1995. Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains. J Cell Biol 129:287-298.
7. Canute GW, Longo SL, Longo JA, Winfield JA, Nevaldine BH, Hahn PJ. 1996. Hydroxyurea accelerates the loss of epidermal growth factor receptor genes amplified as double-minute chromosomes in human glioblastoma multiforme. Neurosurgery 39:976-983.
8. Canute GW, Longo SL, Longo JA, Shetler MM, Coyle TE, Winfield JA, Hahn PJ. 1998. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme. Neurosurgery 42:609-616.
9. Catalan J, Falck GC, Norppa H. 2000. The X chromosome frequently lags behind in female lymphocyte anaphase. Am J Hum Genet 66:687-691. (Pubitemid 30468844)
10. Coindre JM, Hostein I, Maire G, Derre J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A. 2004. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: Histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203:822-830. (Pubitemid 38961569)
11. Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CD, Tallini G. 2000. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 190:531-536. (Pubitemid 30164482)
12. Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM, Von Hoff DD. 1994. Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proc Natl Acad Sci USA 91:6674-6678. (Pubitemid 24200724)
13. Falck GC, Catalan J, Norppa H. 2002. Nature of anaphase laggards and micronuclei in female cytokinesis-blocked lymphocytes. Mutagenesis 17:111-117. (Pubitemid 34232901)
14. Fletcher CD, Akerman M, Dal Cin P, de Wever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, van de Ven W, Vanni R, Willen H. 1996. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol 148:623-630. (Pubitemid 26056746)
15. Fletcher CDM, Unni KK, Mertens F. 2002. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, Lyon, IARCPress, pp. 35-39.
16. Ford JH, Correll AT. 1992. Chromosome errors at mitotic anaphase. Genome 35:702-705.
17. Fukasawa K. 2005. Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6-19. (Pubitemid 41506955)
18. Gisselsson D, Hoglund M, Mertens F, Johansson B, Dal Cin P, Van den Berghe H, Earnshaw WC, Mitelman F, Mandahl N. 1999. The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet 104: 315-325. (Pubitemid 29251150)
19. Gisselsson D, Palsson E, Yu C, Mertens F, Mandahl N. 2004. Mitotic instability associated with late genomic changes in bone and soft tissue tumours. Cancer Lett 206:69-76. (Pubitemid 38281256)
20. Hando JC, Tucker JD, Davenport M, Tepperberg J, Nath J. 1997. X chromosome inactivation and micronuclei in normal and Turner individuals. Hum Genet 100:624-628. (Pubitemid 28072367)
21. Heidenblad M, Hallor KH, Staaf J, Jonsson G, Borg A, Hoglund M, Mertens F, Mandahl N. 2006. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene 25:7106-7116. (Pubitemid 44722078)
22. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M, Mokhtari K, Sanson M, Lejeune J, Aurias A, Delattre O, Delattre JY. 2005. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58:483-487. (Pubitemid 41266639)
23. Imaizumi M, Breitman TR. 1988. Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/ MRI cells. Cancer Res 48:6733-6738. (Pubitemid 19012197)
24. Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre JM, Dumollard JM, Hofman P, Leroux A, Mainguené C, Peyrottes I, Ranchere-Vince D, Terrier P, Tran A, Gual P, Pedeutour F. 2008. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 122:2233-2241. (Pubitemid 351542325)
25. Italiano A, Maire G, Sirvent N, Nuin PA, Keslair F, Foa C, Louis C, Aurias A, Pedeutour F. 2009. Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas. Cancer Lett 273:323-330.
26. Iwasaki H, Ohjimi Y, Ishiguro M, Isayama T, Fujita C, Kaneko Y, Kikuchi M, Shinohara N. 1998. Supernumerary ring chromosomes and nuclear blebs in some low-grade malignant soft tissue tumours: Atypical lipomatous tumours and dermatofibrosarcoma protuberans. Virchows Arch 432:521-528. (Pubitemid 28297559)
27. Kubo A, Nakagawa K, Varma RK, Conrad NK, Cheng JQ, Lee WC, Testa JR, Johnson BE, Kaye FJ, Kelley MJ. 1999. The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4. Clin Cancer Res 5:4279-4286. (Pubitemid 30013816)
28. Macarenco RS, Erickson-Johnson M, Wang X, Jenkins RB, Nascimento AG, Oliveira AM. 2007. Cytogenetic and molecular cytogenetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation. Cancer Genet Cytogenet 172:147-150. (Pubitemid 46043575)
29. Mariani O, Brennetot C, Coindre JM, Gruel N, Ganem C, Delattre O, Stern MH, Aurias A. 2007. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 11:361-374. (Pubitemid 46518313)
30. Menghi-Sartorio S, Mandahl N, Mertens F, Picci P, Knuutila S. 2001. DNA copy number amplifications in sarcomas with homogeneously staining regions and double minutes. Cytometry 46:79-84. (Pubitemid 32423457)
31. Palmer JL, Masui S, Pritchard S, Kalousek DK, Sorensen PH. 1997. Cytogenetic and molecular genetic analysis of a pediatric pleomorphic sarcoma reveals similarities to adult malignant fibrous histiocytoma. Cancer Genet Cytogenet 95:141-147. (Pubitemid 27217121)
32. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C. 1999. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30-41. (Pubitemid 28544460)
33. Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F, Pierotti MA. 1998. Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol 185:188-190. (Pubitemid 28270932)
34. Sandberg AA. 2004. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Liposarcoma. Cancer Genet Cytogenet 155:1-24. (Pubitemid 39446608)
35. Selvarajah S, Yoshimoto M, Park PC, Maire G, Paderova J, Bayani J, Lim G, Al-Romaih K, Squire JA, Zielenska M. 2006. The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma. Chromosoma 115:459-467. (Pubitemid 44642638)
36. Shimizu N, Nakamura H, Kadota T, Kitajima K, Oda T, Hirano T, Utiyama H. 1994. Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells. Cancer Res 54:3561-3567. (Pubitemid 24225984)
37. Shimizu N, Itoh N, Utiyama H, Wahl GM. 1998. Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase. J Cell Biol 140:1307-1320. (Pubitemid 28152981)
38. Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T, Kanda T. 2005. When, where and how the bridge breaks: Anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Exp Cell Res 302:233-243. (Pubitemid 39550465)
39. Sreekantaiah C, Karakousis CP, Leong SP, Sandberg AA. 1992. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 69:2484-2495.
40. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S. 1995. A cytogenetic study of malignant fibrous histiocytoma. Cancer Genet Cytogenet 85:91-96. (Pubitemid 26030363)
41. Tassin AM, Celati C, Moudjou M, Bornens M. 1998. Characterization of the human homologue of the yeast spc98p and its association with c-tubulin. J Cell Biol 141:689-701. (Pubitemid 28217914)
42. Tucker JD, Nath J, Hando JC. 1996. Activation status of the X chromosome in human micronucleated lymphocytes. Hum Genet 97:471-475. (Pubitemid 26081051)
43. Valent A, Benard J, Clausse B, Barrois M, Valteau-Couanet D, Terrier-Lacombe MJ, Spengler B, Bernheim A. 2001. In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol 158:1579-1584.
44. Von Hoff DD, Waddelow T, Forseth B, Davidson K, Scott J, Wahl G. 1991. Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells. Cancer Res 51:6273-6279.
45. Von Hoff DD, McGill JR, Forseth BJ, Davidson KK, Bradley TP, Van Devanter DR, Wahl GM. 1992. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA 89:8165-8169.